These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 29598813)
1. Editorial: The Need of Time: Development of New Antimicrobials. Kaur H Curr Top Med Chem; 2018; 18(1):2. PubMed ID: 29598813 [No Abstract] [Full Text] [Related]
2. Infectious disease 2001: drug resistance, new drugs. Georgopapadakou NH Drug Resist Updat; 2002 Oct; 5(5):181-91. PubMed ID: 12450783 [TBL] [Abstract][Full Text] [Related]
3. Over-the-counter delivery of antibiotics: are we sending the right message? Al-Hamad A Am J Infect Control; 2012 Feb; 40(1):81-2. PubMed ID: 22137194 [No Abstract] [Full Text] [Related]
6. [Problems in the clinical use of antibiotics in China]. Zhang YX Zhonghua Yi Xue Za Zhi; 2003 Mar; 83(5):353-4. PubMed ID: 15558845 [No Abstract] [Full Text] [Related]
7. A crisis is developing in the treatment of infectious diseases. Preface. Champney WS Methods Mol Med; 2008; 142():v-vi. PubMed ID: 18444295 [No Abstract] [Full Text] [Related]
8. Key pathogens and emerging therapies in infectious diseases. Miller PF; Mueller JP Curr Opin Pharmacol; 2009 Oct; 9(5):535-6. PubMed ID: 19766536 [No Abstract] [Full Text] [Related]
9. Less talk, more action. Nat Rev Microbiol; 2013 May; 11(5):295. PubMed ID: 23720828 [No Abstract] [Full Text] [Related]
10. [Clinical and laboratory problems related to the application of antibiotics]. Xiao YH Zhonghua Yi Xue Za Zhi; 2003 Mar; 83(5):357-9. PubMed ID: 15559879 [No Abstract] [Full Text] [Related]
12. [The statement from 6 infectious diseases-related academic societies towards the further understanding of the necessity for the innovation/development of novel antimicrobials and the current status of antibiotic-resistant bacteria]. Kansenshogaku Zasshi; 2014 Jul; 88(4):409-16. PubMed ID: 25199373 [No Abstract] [Full Text] [Related]
13. The role of new antibiotics for the treatment of infections in the emergency department. Talan DA Ann Emerg Med; 1994 Sep; 24(3):473-89. PubMed ID: 8080145 [TBL] [Abstract][Full Text] [Related]
14. Antimicrobial Resistance: Challenges and the Way Forward. Shariff M Indian J Chest Dis Allied Sci; 2016 Jul; 58(3):157-159. PubMed ID: 30152647 [No Abstract] [Full Text] [Related]
15. EDITORIAL: New Avenues in Controlling Infectious Diseases. Rathi B; Latha N; Faletrov Y; Bhargava P; Shkumatov V Curr Top Med Chem; 2017; 17(19):2113. PubMed ID: 28664823 [No Abstract] [Full Text] [Related]
16. [Antibiotic strategy in an infectious diseases unit]. Dupon M Presse Med; 2000 Jan; 29(2):121-3. PubMed ID: 10682044 [No Abstract] [Full Text] [Related]
17. Antimicrobial activity of eugenol and essential oils containing eugenol: A mechanistic viewpoint. Marchese A; Barbieri R; Coppo E; Orhan IE; Daglia M; Nabavi SF; Izadi M; Abdollahi M; Nabavi SM; Ajami M Crit Rev Microbiol; 2017 Nov; 43(6):668-689. PubMed ID: 28346030 [TBL] [Abstract][Full Text] [Related]
18. Global antimicrobial resistance alerts and implications. Levy SB; O'Brien TF; Clin Infect Dis; 2005 Aug; 41 Suppl 4():S219-20. PubMed ID: 16032554 [No Abstract] [Full Text] [Related]
19. The amazing world of antibiotics. Sánchez S; Demain AL Biochem Pharmacol; 2017 Jun; 133():1-3. PubMed ID: 28288822 [No Abstract] [Full Text] [Related]
20. The benefits and risks of mass antibiotic use for reducing child mortality. Bhutta ZA Nat Med; 2019 Sep; 25(9):1332-1334. PubMed ID: 31501607 [No Abstract] [Full Text] [Related] [Next] [New Search]